Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Roy M Anderson

Showing results (51-60 of 145) with videos related to

Pageof 15
Sort By:
Scientific Reports|September 5, 2020
Association of TDP-43 proteinopathy, cerebral amyloid angiopathy, and Lewy bodies with cognitive impairment in individuals with or without Alzheimer's disease neuropathologyDavid X Thomas, Sumali Bajaj, Kevin McRae-McKee, et al.
Plos One|August 25, 2022
A prevalence-based transmission model for the study of the epidemiology and control of soil-transmitted helminthiasisNyuk Sian Chong, Robert J Hardwick, Stacey R Smith, et al.
Plos Neglected Tropical Diseases|June 2, 2025
How improvements to drug effectiveness impact mass drug administration for control and elimination of schistosomiasisJohn R Ellis, Nyamai Mutono, Andreia Vasconcelos, et al.
Plos One|July 2, 2016
How Can Viral Dynamics Models Inform Endpoint Measures in Clinical Trials of Therapies for Acute Viral Infections?Carolin Vegvari, Christoforos Hadjichrysanthou, Emilie Cauët, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|September 28, 2005
Mortality in patients with successful initial response to highly active antiretroviral therapy is still higher than in non-HIV-infected individualsArd van Sighem, Sven Danner, Azra C Ghani, et al.
European Journal of Immunology|August 13, 2004
Determining control parameters for dendritic cell-cytotoxic T lymphocyte interactionBurkhard Ludewig, Philippe Krebs, Tobias Junt, et al.
Parasites & Vectors|November 18, 2020
The impact of mass drug administration on Schistosoma haematobium infection: what is required to achieve morbidity control and elimination?Klodeta Kura, Robert J Hardwick, James E Truscott, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|April 27, 2021
Impact of Key Assumptions About the Population Biology of Soil-Transmitted Helminths on the Sustainable Control of MorbidityCarolin Vegvari, Federica Giardina, Veronica Malizia, et al.
Proceedings of the National Academy of Sciences of the United States of America|September 1, 2007
Critique of early models of the demographic impact of HIV/AIDS in sub-Saharan Africa based on contemporary empirical data from ZimbabweSimon Gregson, Constance Nyamukapa, Ben Lopman, et al.
AIDS (London, England)|March 2, 2002
Study of bias in antenatal clinic HIV-1 surveillance data in a high contraceptive prevalence population in sub-Saharan AfricaSimon Gregson, Nicola Terceira, Memory Kakowa, et al.
Pageof 15

Showing results (51-60 of 145) with videos related to

Sort By:
Pageof 15
Scientific Reports|September 5, 2020
Association of TDP-43 proteinopathy, cerebral amyloid angiopathy, and Lewy bodies with cognitive impairment in individuals with or without Alzheimer's disease neuropathologyDavid X Thomas, Sumali Bajaj, Kevin McRae-McKee, et al.
Plos One|August 25, 2022
A prevalence-based transmission model for the study of the epidemiology and control of soil-transmitted helminthiasisNyuk Sian Chong, Robert J Hardwick, Stacey R Smith, et al.
Plos Neglected Tropical Diseases|June 2, 2025
How improvements to drug effectiveness impact mass drug administration for control and elimination of schistosomiasisJohn R Ellis, Nyamai Mutono, Andreia Vasconcelos, et al.
Plos One|July 2, 2016
How Can Viral Dynamics Models Inform Endpoint Measures in Clinical Trials of Therapies for Acute Viral Infections?Carolin Vegvari, Christoforos Hadjichrysanthou, Emilie Cauët, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|September 28, 2005
Mortality in patients with successful initial response to highly active antiretroviral therapy is still higher than in non-HIV-infected individualsArd van Sighem, Sven Danner, Azra C Ghani, et al.
European Journal of Immunology|August 13, 2004
Determining control parameters for dendritic cell-cytotoxic T lymphocyte interactionBurkhard Ludewig, Philippe Krebs, Tobias Junt, et al.
Parasites & Vectors|November 18, 2020
The impact of mass drug administration on Schistosoma haematobium infection: what is required to achieve morbidity control and elimination?Klodeta Kura, Robert J Hardwick, James E Truscott, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|April 27, 2021
Impact of Key Assumptions About the Population Biology of Soil-Transmitted Helminths on the Sustainable Control of MorbidityCarolin Vegvari, Federica Giardina, Veronica Malizia, et al.
Proceedings of the National Academy of Sciences of the United States of America|September 1, 2007
Critique of early models of the demographic impact of HIV/AIDS in sub-Saharan Africa based on contemporary empirical data from ZimbabweSimon Gregson, Constance Nyamukapa, Ben Lopman, et al.
AIDS (London, England)|March 2, 2002
Study of bias in antenatal clinic HIV-1 surveillance data in a high contraceptive prevalence population in sub-Saharan AfricaSimon Gregson, Nicola Terceira, Memory Kakowa, et al.
Pageof 15